Manufacturer of Controlled Substances; Notice of Registration, 4832-4833 [2012-1977]
Download as PDF
<![CDATA[
4832
Federal Register / Vol. 77, No. 20 / Tuesday, January 31, 2012 / Notices
that on September 12, 2011,
Mallinckrodt LLC., 3600 North Second
Street, St. Louis, Missouri 63147, made
application by renewal to the Drug
Enforcement Administration (DEA) for
registration as an importer of the
following basic classes of controlled
substances:
Drug
Schedule
wreier-aviles on DSK5TPTVN1PROD with NOTICES
Methylphenidate (1724) ................
Phenylacetone (8501) ..................
Coca Leaves (9040) .....................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
Fentanyl (9801) ............................
II
II
II
II
II
II
II
II
II
II
15:20 Jan 30, 2012
Jkt 226001
Dated: January 23, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: January 23, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–1979 Filed 1–30–12; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2012–1980 Filed 1–30–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
The company plans to import the
listed controlled substances to
manufacture bulk controlled substances
for distribution to its customers, and for
research and analytical standards.
No comments, objections, or requests
for any hearings will be accepted on any
application for registration or reregistration to import crude opium,
poppy straw, poppy straw concentrate,
and coca leaves. As explained in the
Correction to Notice of Application
pertaining to 72 FR 3417 (2007),
comments and requests for hearings on
applications to import narcotic raw
material are not appropriate.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedule I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act 21 U.S.C. 952
(a)(2)(B) may, in the circumstances set
forth in 21 U.S.C. 958(i), file comments
or objections to the issuance of the
proposed registration and may, at the
same time, file a written request for a
hearing on such application pursuant to
21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than March 1, 2012.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f).
As noted in a previous notice
published in the Federal Register on
September 23, 1975, 40 FR 43745–46,
all applicants for registration to import
a basic class of any controlled substance
VerDate Mar<15>2010
in schedule I or II are, and will continue
to be, required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Drug Enforcement Administration
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
Importer of Controlled Substances;
Notice of Registration
By Notice dated June 23, 2011, and
published in the Federal Register on
July 5, 2011, 76 FR 39127, Cayman
Chemical Company, 1180 East Ellsworth
Road, Ann Arbor, Michigan 48108,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
By Notice dated June 1, 2011, and
published in the Federal Register on
June 9, 2011, 76 FR 33784, Alltech
Associates, Inc., 2051 Waukegan Road,
Deerfield, Illinois 60015, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the
following basic classes of controlled
substances:
Drug
Schedule
Gamma
Hydroxybutyric
Acid
(2010).
Heroin (9200) ...............................
Lysergic acid diethylamide (7315)
Cocaine (9041) .............................
Codeine (9050) .............................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Methadone (9250) ........................
Morphine (9300) ...........................
I
I
I
II
II
II
II
II
II
The company plans to import these
controlled substances for the
manufacture of reference standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Alltech Associates, Inc. to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Alltech Associates, Inc.
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
Drug
Cathinone (1235) ..........................
Methcathinone (1237) ..................
N-Ethylamphetamine (1475) ........
N,N-Dimethylamphetamine (1480)
Aminorex (1585) ...........................
4-Methylaminorex (cis isomer)
(1590).
1-Pentyl-3-(1-naphthoyl)indole
(7118).
1-Butyl-3-(1-naphthoyl)indole
(7173).
1-[2-(4-Morpholinyl)ethyl]-3-(1naphthoyl) Indole (7200).
Alpha-ethyltryptamine (7249) .......
5-(1,1-Dimethylheptyl)-2-[(1R,3S)3-hydroxycyclohexyl]-phenol
(7297).
5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl]-phenol
(7298).
Lysergic acid diethylamide (7315)
2,5-Dimethoxy-4-(n)propylthiophenethylamine
(7348).
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
3,4,5-Trimethoxyamphetamine
(7390).
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
E:\FR\FM\31JAN1.SGM
31JAN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Federal Register / Vol. 77, No. 20 / Tuesday, January 31, 2012 / Notices
Schedule
Drug
wreier-aviles on DSK5TPTVN1PROD with NOTICES
2,5-Dimethoxy-4ethylamphetamine (7399).
3,4-Methylenedioxyamphetamine
(7400).
5-Methoxy-3,4methylenedioxyamphetamine
(7401).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (7405).
4-Methoxyamphetamine (7411) ...
5-Methoxy-N-Ndimethyltryptamine (7431).
Alpha-methyltryptamine (7432) ....
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
5-Methoxy-N,Ndiisopropyltryptamine (7439).
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Lisdexamfetamine (1205) .............
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
I
Drug Enforcement Administration
Federal Bureau of Investigation
I
Manufacturer of Controlled
Substances; Notice of Registration
[OMB Number 1110–0004]
I
By Notice dated June 7, 2011, and
published in the Federal Register on
June 16, 2011, 76 FR 35243, Archimica,
Inc., 2460 W. Bennett Street,
Springfield, Missouri 65807–1229, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
I
I
I
I
I
Drug
I
I
I
I
Schedule
Gamma
Hydroxybutyric
Acid
(2010).
Amphetamine (1100) ....................
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Phenylacetone (8501) ..................
Methadone Intermediate (9254) ...
Tapentadol (9780) ........................
II
II
II
I
II
II
II
II
II
II
The company plans to manufacture
small quantities of marihuana
derivatives for research purposes. In
reference to drug code 7360
(Marihuana), the company plans to bulk
manufacture cannabidiol. In reference to
drug code 7370
(Tetrahydrocannabinols), the company
will manufacture a synthetic THC. No
other activity for this drug code is
authorized for this registration.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cayman Chemical Company to
manufacture the listed basic classed of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Cayman Chemical
Company to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
The company plans to manufacture
the listed controlled substances in bulk
for distribution and sale to its customers
for Amphetamine (1100).
The company plans to acquire the
listed controlled substances in bulk
from a domestic source in order to
manufacture other controlled substances
in bulk for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Archimica, Inc., to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Archimica, Inc., to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: January 23, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Dated: January 23, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–1977 Filed 1–30–12; 8:45 am]
[FR Doc. 2012–1981 Filed 1–30–12; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
VerDate Mar<15>2010
15:20 Jan 30, 2012
4833
Jkt 226001
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Agency Information Collection
Activities; Proposed Collection,
Comments Requested: Extension of a
Currently Approved Collection;
Number of Full-Time Law Enforcement
Employees as of October 31
30-day Notice of Information
Collection Under Review.
ACTION:
The Department of Justice, Federal
Bureau of Investigation, Criminal Justice
Information Services Division (CJIS)
will be submitting the following
information collection request to the
Office of Management and Budget
(OMB) for review and clearance in
accordance with established review
procedures of the Paperwork Reduction
Act of 1995. The proposed information
collection is published to obtain
comments from the public and affected
agencies. This proposed information
collection was previously published in
the Federal Register Volume 76,
Number 228, page 72977, on November
28, 2011, allowing for a 60 day comment
period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until March 1, 2012. This
process is conducted in accordance with
5 CFR 1320.10.
Written comments and/or suggestions
regarding the items contained in this
notice, especially the estimated public
burden and associated response time,
should be directed to Mr. Gregory E.
Scarbro, Unit Chief, Federal Bureau of
Investigation, CJIS Division, Module E–
3, 1000 Custer Hollow Road, Clarksburg,
West Virginia 26306; facsimile (304)
625–3566.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Comments
should address one or more of the
following four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
E:\FR\FM\31JAN1.SGM
31JAN1
]]>Agencies
[Federal Register Volume 77, Number 20 (Tuesday, January 31, 2012)]
[Notices]
[Pages 4832-4833]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-1977]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 23, 2011, and published in the Federal
Register on July 5, 2011, 76 FR 39127, Cayman Chemical Company, 1180
East Ellsworth Road, Ann Arbor, Michigan 48108, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the following basic classes of controlled
substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................... I
Methcathinone (1237)....................... I
N-Ethylamphetamine (1475).................. I
N,N-Dimethylamphetamine (1480)............. I
Aminorex (1585)............................ I
4-Methylaminorex (cis isomer) (1590)....... I
1-Pentyl-3-(1-naphthoyl)indole (7118)...... I
1-Butyl-3-(1-naphthoyl)indole (7173)....... I
1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) I
Indole (7200).
Alpha-ethyltryptamine (7249)............... I
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3- I
hydroxycyclohexyl]-phenol (7297).
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3- I
hydroxycyclohexyl]-phenol (7298).
Lysergic acid diethylamide (7315).......... I
2,5-Dimethoxy-4-(n)- I
propylthiophenethylamine (7348).
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
3,4,5-Trimethoxyamphetamine (7390)......... I
4-Bromo-2,5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
4-Methyl-2,5-dimethoxyamphetamine (7395)... I
2,5-Dimethoxyamphetamine (7396)............ I
[[Page 4833]]
2,5-Dimethoxy-4-ethylamphetamine (7399).... I
3,4-Methylenedioxyamphetamine (7400)....... I
5-Methoxy-3,4-methylenedioxyamphetamine I
(7401).
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymethamphetamine (7405)... I
4-Methoxyamphetamine (7411)................ I
5-Methoxy-N-N-dimethyltryptamine (7431).... I
Alpha-methyltryptamine (7432).............. I
Diethyltryptamine (7434)................... I
Dimethyltryptamine (7435).................. I
5-Methoxy-N,N-diisopropyltryptamine (7439). I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Lisdexamfetamine (1205).................... II
------------------------------------------------------------------------
The company plans to manufacture small quantities of marihuana
derivatives for research purposes. In reference to drug code 7360
(Marihuana), the company plans to bulk manufacture cannabidiol. In
reference to drug code 7370 (Tetrahydrocannabinols), the company will
manufacture a synthetic THC. No other activity for this drug code is
authorized for this registration.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cayman Chemical Company to manufacture the listed basic classed of
controlled substances is consistent with the public interest at this
time. DEA has investigated Cayman Chemical Company to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance
with 21 CFR 1301.33, the above named company is granted registration as
a bulk manufacturer of the basic classes of controlled substances
listed.
Dated: January 23, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-1977 Filed 1-30-12; 8:45 am]
BILLING CODE 4410-09-P
